Human embryonic stem cell derived mesenchymal progenitors express cardiac markers but do not form contractile cardiomyocytes.
Mesenchymal progenitors or stromal cells have shown promise as a therapeutic strategy for a range of diseases including heart failure. In this context, we explored the growth and differentiation potential of mesenchymal progenitors (MPs) derived in vitro from human embryonic stem cells (hESCs). Simi...
Guardado en:
Autores principales: | Christophe M Raynaud, Najeeb Halabi, David A Elliott, Jennifer Pasquier, Andrew G Elefanty, Edouard G Stanley, Arash Rafii |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0f8d6f2e4bdf4764a1303b457b9df14b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Acute effects of cardiac contractility modulation on human induced pluripotent stem cell–derived cardiomyocytes
por: Tromondae K. Feaster, et al.
Publicado: (2021) -
Enhanced nanomagnetic gene transfection of human prenatal cardiac progenitor cells and adult cardiomyocytes.
por: Mahendran Subramanian, et al.
Publicado: (2013) -
Analysis of mitochondrial function and localisation during human embryonic stem cell differentiation in vitro.
por: Andrew B J Prowse, et al.
Publicado: (2012) -
Automatic detection of adult cardiomyocyte for high throughput measurements of calcium and contractility.
por: L Cao, et al.
Publicado: (2021) -
Promoter interactome of human embryonic stem cell-derived cardiomyocytes connects GWAS regions to cardiac gene networks
por: Mun-Kit Choy, et al.
Publicado: (2018)